Clinical Trials Sponsored by Bristol Myers Squibb Srl Italia
Total 2671 results
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbActive, not recruiting
-
Bristol-Myers SquibbTerminatedAtrial FibrillationCanada, United States
-
Bristol-Myers SquibbWithdrawn
-
Bristol-Myers SquibbActive, not recruitingMultiple SclerosisUnited States
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, Poland, United States, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Greece, Netherlands, Norway, Romania, Spain, Switzerland, United Kingdom, Sweden
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
Bristol-Myers SquibbCompletedDermatitis, AtopicGermany, Australia, Poland, Canada, Austria, United States, Spain
-
Bristol-Myers SquibbActive, not recruitingRecurrent GlioblastomaPoland, United Kingdom, United States, Spain, Australia, Germany, Italy, Denmark, Belgium, France, Netherlands, Switzerland
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and NeckChina
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Romania, Spain, Switzerland, United Kingdom
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, United States, Germany, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Finland, France, Greece, Israel, Mexico, New Zealand, Norway, Poland, Romania, Russian Federation, Spain, Sweden, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerFrance, United States, Spain, Australia, Italy, Switzerland, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingMelanomaUnited States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Mexico, Norway, Romania, Spain, Sweden, Switzerland, United Kingdom
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedPan TumorUnited States, Puerto Rico, Italy, Argentina, Australia, Belgium, Canada, Chile, Denmark, France, Germany, Netherlands, Poland, Romania, Singapore, Spain, United Kingdom
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbActive, not recruitingKidney Cancer | Renal Cell Carcinoma | Renal Cell Cancer | Adenocarcinoma Of Kidney | Adenocarcinoma, Renal Cell | Cancer of the KidneyFrance
-
Bristol-Myers SquibbTerminatedLymphoma | Leukemia, Lymphocytic, Chronic, B-CellSpain, United States
-
Bristol-Myers SquibbCompletedActive Polyarticular Juvenile Idiopathic ArthritisUnited States, Spain, Belgium, Italy, Argentina, Brazil, France, Germany, Mexico, Peru, Russian Federation, South Africa
-
Bristol-Myers SquibbCompletedAdvanced Pancreatic CancerUnited States, Canada, Germany, United Kingdom, Taiwan, Italy, Korea, Republic of, Switzerland, Denmark, Japan, Spain
-
Bristol-Myers SquibbCompletedColorectal Cancer | Pancreatic CancerUnited States, Australia, Belgium, Canada, Germany, Spain
-
Bristol-Myers SquibbCompletedLung CancerItaly, United States, France, Russian Federation, Spain, Argentina, Belgium, Brazil, Canada, Chile, Czechia, Germany, Greece, Hungary, Mexico, Netherlands, Poland, Romania, Switzerland, Turkey, United Kingdom
-
Bristol-Myers SquibbCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicChina
-
Bristol-Myers SquibbActive, not recruiting
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbWithdrawnMelanoma | Urothelial CarcinomaGermany, Spain
-
Bristol-Myers SquibbCompletedMalignant Solid TumorUnited States, France, Italy, Australia, Canada, Germany, Netherlands
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompletedSolid TumorsUnited States, Australia, Spain, Germany, France, Switzerland, Netherlands, Canada, Belgium, Italy
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand
-
Bristol-Myers SquibbActive, not recruiting
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompletedSystemic Lupus ErythematosusTaiwan, United States, Hungary, Argentina, Canada, Spain, Japan, Poland, Russian Federation, Korea, Republic of, Israel, Romania, Mexico, Australia, Brazil, Colombia, Germany
-
Bristol-Myers SquibbCompletedPsoriasisUnited States, Spain, Hungary, Australia, Germany, Canada, Czechia, Poland, Puerto Rico, Finland, France, Israel, Italy, New Zealand, Sweden, United Kingdom
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Israel, Australia, Austria, Canada, Italy
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedRenal Cell CarcinomaUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD) | Hepatic CirrhosisUnited States, Japan
-
Bristol-Myers SquibbTerminatedCOVID-19 | SARS-CoV-2Puerto Rico, United States
-
Bristol-Myers SquibbCompleted